5-Cyclopropyl-4-ethyl-4H-1,2,4-triazole-3-thiol

Catalog No. :
ACJVBR385
CAS No. :
443918-29-4
Molecular Formula :
C7H11N3S
Molecular Weight :
169.25

IUPAC Name:5-cyclopropyl-4-ethyl-4H-1,2,4-triazole-3-thiol

5-Cyclopropyl-4-ethyl-4H-1,2,4-triazole-3-thiol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$76.00Login to see priceInquiryInquiry
100mg95%$106.00Login to see priceInquiryInquiry
250mg95%$145.00Login to see priceInquiryInquiry
1g95%$274.00Login to see priceInquiryInquiry
5g95%$719.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Cyclopropyl-4-ethyl-4H-1,2,4-triazole-3-thiol
IUPAC Name5-cyclopropyl-4-ethyl-4H-1,2,4-triazole-3-thiol
MDL No.MFCD03421741
Molecular FormulaC7H11N3S
Molecular Weight169.25
SMILESSC1=NN=C(C2CC2)N1CC
InChI KeyNVQGFMFSJHMAJB-UHFFFAOYSA-N
SynonymART-CHEM-BB B008195;CHEMBRDG-BB 3008195;5-CYCLOPROPYL-4-ETHYL-4 H-[1,2,4]TRIAZOLE-3-THIOL;AKOS B008195;Albb-003231;5-cyclopropyl-4-ethyl-4H-1,2,4-triazole-3-thiol(SALTDATA: FREE);3H-1,2,4-Triazole-3-thione, 5-cyclopropyl-4-ethyl-2,4-dihydro-
CAS No.443918-29-4
PubChem CID3372156

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P233-P260-P261-P264-P271-P280-P302+P352-P304-P304+P340-P305+P351+P338-P312-P321-P332+P313-P337+P313-P340-P362-P403-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACJVBR385 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJVBR385 route product structure diagram
    ACJVBR385443918-29-4
Inquiry

2. ACJVBR385 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJVBR385 route product structure diagram
    ACJVBR385443918-29-4
Inquiry

Comments (0)